Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 2 |
Cisco
CSCO
|
+$327M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$305M |
| 4 |
Archer Daniels Midland
ADM
|
+$174M |
| 5 |
Johnson & Johnson
JNJ
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$688M |
| 2 |
Royal Bank of Canada
RY
|
+$526M |
| 3 |
Toronto Dominion Bank
TD
|
+$457M |
| 4 |
Scotiabank
BNS
|
+$414M |
| 5 |
Canadian National Railway
CNI
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.54% |
| 2 | Energy | 14.01% |
| 3 | Miscellaneous | 12.57% |
| 4 | Industrials | 8.26% |
| 5 | Technology | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Oceaneering
OII
$4.42B
| $556K | ﹤0.01% |
8,511
-2,528
| -23% | -$175K |
2013 Q2
5 quarters
|
|
|
CPLA
2027
DELISTED
Capella Education Company
CPLA
| $555K | ﹤0.01% |
8,857
-277
| -3% | -$17.2K |
2013 Q2
5 quarters
|
|
|
OREX
2028
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $555K | ﹤0.01% |
13,030
+4,480
| +52% | +$241K |
2014 Q2
1 quarter
|
|
2029
W.P. Carey
WPC
$14.5B
| $554K | ﹤0.01% |
8,885
+590
| +7% | +$38.6K |
2013 Q2
5 quarters
|
|
|
WRI
2030
CALL
DELISTED
Weingarten Realty Investors
WRI
| $554K | ﹤0.01% |
+17,600
| New | +$585K |
2014 Q3
0 quarters
|
|
|
SSRI
2031
CALL
DELISTED
Silver Standard Resources
SSRI
| $554K | ﹤0.01% |
90,800
-16,900
| -16% | -$144K |
2014 Q1
2 quarters
|
|
2032
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.3B
| $553K | ﹤0.01% |
5,410
| – | – |
2013 Q2
5 quarters
|
|
|
MN
2033
DELISTED
MANNING & NAPIER, INC.
MN
| $552K | ﹤0.01% |
32,913
-776
| -2% | -$13.6K |
2013 Q2
5 quarters
|
|
2034
Cirrus Logic
CRUS
$6.02B
| $551K | ﹤0.01% |
26,441
-2,760
| -9% | -$63.9K |
2013 Q2
5 quarters
|
|
|
ALO
2035
DELISTED
Alio Gold Inc
ALO
| $551K | ﹤0.01% |
42,714
-9,528
| -18% | -$159K |
2013 Q2
5 quarters
|
|
2036
iShares MSCI South Korea ETF
EWY
$26.7B
| $550K | ﹤0.01% |
9,082
+3,463
| +62% | +$225K |
2013 Q2
5 quarters
|
|
|
QIHU
2037
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $550K | ﹤0.01% |
8,145
+1,343
| +20% | +$120K |
2013 Q2
5 quarters
|
|
2038
Omnicell
OMCL
$1.53B
| $546K | ﹤0.01% |
19,970
-772
| -4% | -$21.1K |
2013 Q2
5 quarters
|
|
|
SSRI
2039
DELISTED
Silver Standard Resources
SSRI
| $546K | ﹤0.01% |
89,530
+3,056
| +4% | +$26.1K |
2013 Q2
5 quarters
|
|
|
SGMO
2040
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $545K | ﹤0.01% |
50,580
-10,120
| -17% | -$132K |
2014 Q1
2 quarters
|
|
2041
Benchmark Electronics
BHE
$3.04B
| $544K | ﹤0.01% |
24,529
-1,604
| -6% | -$38.9K |
2013 Q2
5 quarters
|
|
2042
Comstock Resources
CRK
$3.77B
| $540K | ﹤0.01% |
5,789
+347
| +6% | +$41.2K |
2013 Q2
5 quarters
|
|
2043
ServiceNow
NOW
$142B
| $540K | ﹤0.01% |
45,985
+1,965
| +4% | +$23.2K |
2013 Q2
5 quarters
|
|
|
SYKE
2044
DELISTED
SYKES Enterprises Inc
SYKE
| $540K | ﹤0.01% |
27,086
+2,628
| +11% | +$54.6K |
2013 Q2
5 quarters
|
|
|
HOLX
2045
DELISTED
Hologic
HOLX
| $539K | ﹤0.01% |
22,167
+372
| +2% | +$9.39K |
2013 Q2
5 quarters
|
|
2046
CONMED
CNMD
$1.38B
| $538K | ﹤0.01% |
14,624
-690
| -5% | -$27.4K |
2013 Q2
5 quarters
|
|
2047
Healthcare Realty
HR
$5.97B
| $538K | ﹤0.01% |
23,169
-10,782
| -32% | -$262K |
2013 Q2
5 quarters
|
|
2048
Liberty Media Corporation Series C Common Stock
FWONK
$23B
| $536K | ﹤0.01% |
+21,295
| New | +$545K |
2014 Q3
0 quarters
|
|
|
EGL
2049
DELISTED
Engility Holdings, Inc.
EGL
| $535K | ﹤0.01% |
17,165
-577
| -3% | -$20.3K |
2013 Q2
5 quarters
|
|
|
BIG
2050
DELISTED
Big Lots, Inc.
BIG
| $534K | ﹤0.01% |
12,398
+421
| +4% | +$19.2K |
2013 Q2
5 quarters
|
|
Similar funds
Bank of Montreal's Q3 2014 Portfolio in Review
As of Q3 2014, Bank of Montreal held 5,003 positions worth $88.3B, down 1.4% from $89.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal's Q3 2014 filing shows 320 new, 1,431 increased, 1,887 reduced and 935 closed positions. Its largest new stake was Cisco: 13,004,651 shares worth $327M. The largest sale was Apple, an estimated $688M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q3 2014 buy was Cisco: 13,004,651 shares worth $327M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $381M increase.
- Bank of Montreal's biggest Q3 2014 reduction was Apple, cutting an estimated $688M.
- Bank of Montreal fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $15M.
- Bank of Montreal's ten largest holdings make up 23% of its $88.3B portfolio in Q3 2014.
- Bank of Montreal opened 320 new positions and closed 935 in Q3 2014.
- Bank of Montreal's portfolio value fell 1.4% quarter-over-quarter to $88.3B.
Based on Bank of Montreal's 13F filing for Q3 2014, filed 7 Nov 2014.